Kanpime TZ 500mg/62.5mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Cefepime (500mg) + Tazobactum (62.5mg)
Overview Kanpime TZ 500mg/62.5mg Injection
Tazicef 500mg/62.5mg injectable solution combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be solely under a physician's guidance; adhere strictly to the prescribed dosage schedule. Complete the entire course, regardless of symptom improvement. Commonly reported adverse effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but typically resolve spontaneously. Worsening side effects require immediate medical attention. Seek immediate medical assistance for allergic reactions (skin rashes, itching, swelling, respiratory distress). Prior to commencing treatment, inform your doctor of all current medications and existing health conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness ensues.
Primary Ingredients of Kanpime TZ 500mg/62.5mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Kanpime TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Kanpime TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Kanpime TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Kanpime TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kanpime TZ 500mg/62.5mg Injection works:
Kanpime TZ 500mg/62.5mg Injection unites cefepime, a bacterial growth inhibitor, with tazobactam, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counters bacterial enzymes that otherwise deactivate cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Kanpime TZ 500mg/62.5mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Kanpime TZ 500mg/62.5mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Kanpime TZ (500mg/62.5mg) presents no known breastfeeding contraindications. Research in humans indicates minimal drug transfer to breast milk, posing negligible risk to the infant.
DrivingUNSAFE
Following administration of Kanpime TZ 500mg/62.5mg Injection, temporary blurred vision may occur. Refrain from operating a vehicle until visual acuity returns to normal.
KidneyCAUTION
Administering Kanpime TZ 500mg/62.5mg Injection to individuals with impaired renal function requires careful monitoring. Dosage modifications for Kanpime TZ 500mg/62.5mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Kanpime TZ 500mg/62.5mg Injection in patients with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Kanpime TZ 500mg/62.5mg Injection :
Should you forget a scheduled Kanpime TZ 500mg/62.5mg Injection, seek your physician's advice.
Facts to Know About Kanpime TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently